Masayuki Furukawa

6PUBLICATIONS
51CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 05, 2026
Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis.

Lingaku Lee, Yuichi Tachibana, Susumu Matsuo

|Jul 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Akihiro Ohba, Masato Ozaka, Junki Mizusawa

|Apr 10, 2025
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer.

Kanae Inoue, Yoshiaki Nakamura, Bennett Caughey

|Jul 26, 2024
A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy.

Junji Furuse, Masafumi Ikeda, Makoto Ueno

|Apr 17, 2024
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B.

Yasuyuki Kawamoto, Chigusa Morizane, Yoshito Komatsu

|Sep 02, 2023
Zinc Deficiency as a General Feature of Cancer: a Review of the Literature.

Rie Sugimoto, Lingaku Lee, Yuki Tanaka

Pageof 1

Frequent Collaborators

4 joint publications

Masafumi Ikeda

3 joint publications

Makoto Ueno

2 joint publications

Rie Sugimoto

2 joint publications

Lingaku Lee